Media Spotlight: Stem Cell Research and Real Estate Icon
|
Embryonic stem cells hold incredible promise for the development of treatments for all retinal degenerative diseases.
To address this issue, Foundation science leaders Dr. Stephen Rose, chief research officer, and Dr. Steven Bramer, chief drug development officer, advocated for increased federal support for embryonic stem cell research in an opinion editorial that was published on The Hill’s Congress Blog. In a separate Nature article, Dr. Rose addressed the Foundation’s inability to directly fund Advanced Cell Technology’s clinical trial for treating Stargardt disease, a study that uses retinal cells derived from embryonic stem cells. |














![Casting A Wide Net[work] | Presenting the interactive Foundation Fighting Blindness 2012 Annual Report 2012 Annual Report banner](https://www.blindness.org/images/banners/annual_report_box.jpg)


